Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, PR China.
Pharm Biol. 2011 May;49(5):445-55. doi: 10.3109/13880209.2010.523426.
Chinese herbal medicine (CHM) is a complex multicomponent complex system that interacts with multiple targets and functions via multiple pathways based on the whole human system. Therefore, identification of key constituents of Chinese herbals (CH) not only plays a critical role in the quality control of CHM, but also paves a basis for redevelopment of them.
Identification of key constituents in volatile oil (VO) of Ligusticum chuanxiong Hort (Umbelliferae) (LCH), which is a CHM clinically used in China thousands of years ago.
The VO of LCH was pharmacologically demonstrated to have blood vessel activity (BVA) in vitro and chemically investigated by gas chromatography-mass spectrometry (GC-MS) analysis. Data mining approaches were used to bridge the gap between chemical constituents (CCS) and bioactivities as well as contribute to select key constituents of LCH automatically.
Thirteen effective constituents of LCH with significant association with BVA were identified.
The combination of 13 key constituents would accurately predict the bioactivities of blood vessel of LCH. Furthermore, the strategy presented here paves a strong basis for identification of key constituents of CH and elucidation of material basis of CHM.
中药是一个复杂的多成分复杂体系,基于整体人体系统,通过多途径与多个靶点和功能相互作用。因此,鉴定中药的关键成分不仅对中药的质量控制起着至关重要的作用,而且为它们的重新开发奠定了基础。
鉴定临床应用于中国数千年的伞形科藁本属川芎(Ligusticum chuanxiong Hort)挥发油(VO)中的关键成分。
体外药理学研究表明,LCH 的 VO 具有血管活性(BVA),并用气相色谱-质谱(GC-MS)分析进行了化学研究。数据挖掘方法被用来弥合化学成分(CCS)和生物活性之间的差距,并有助于自动选择 LCH 的关键成分。
鉴定出与 BVA 有显著关联的 13 种 LCH 的有效成分。
这 13 种关键成分的组合将能准确预测 LCH 血管的生物活性。此外,这里提出的策略为鉴定中药的关键成分和阐明中药的物质基础奠定了坚实的基础。